Enanta Pharmaceuticals (ENTA) came out with a quarterly loss of $1.36 per share versus the Zacks Consensus Estimate of a loss of $1.16. This compares to loss of $1.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -17.24%. A quarter ago, it was expected that this biotechnology company would post a loss of $1.49 per share when it actually produced a loss of $1.07, delivering a surprise of 28.19%.Over the last four quarters, th ...